i-Health bolsters probiotic lineup with UP4 acquisition

Press enter to search
Close search
Open Menu

i-Health bolsters probiotic lineup with UP4 acquisition

By Michael Johnsen - 02/01/2017

CROMWELL, Conn. — i-Health, a wholly owned subsidiary of Royal DSM, announced Tuesday that it has entered into an agreement to purchase the UP4 Probiotic brand from UAS Laboratories.  UP4 is a successful specialty channel brand that features a full line of probiotic products.



Terms of the deal were not disclosed.



"The acquisition of the successful, fast growing and scientifically supported UP4 brand of probiotics will expand and accelerate i-Health's leadership position in the probiotic category," stated Wes Parris, i-Health's CEO.  "I am excited about the prospect of delivering even more new growth platforms based on strong science and innovation into the fast growing probiotic category.  In addition, the UP4 brand represents a perfect strategic complement to our category leading brand Culturelle."   


In addition to Culturelle, UP4 joins i-Health's other leading women's health brands AZO and Estroven.



"I am thankful and proud of the talented and passionate team at UAS Labs that built UP4 Probiotics into a compelling brand that resonates with today's consumers," added Kevin Mehring, UAS Labs CEO.  "Their efforts helped expand the brand in health food stores plus gain distribution in Target, grocery and specialty supplement stores nationwide. We know the experienced team at i-Health, will build upon this growth and take the UP4 brand to the next level ultimately helping more consumers live a healthier life with our probiotic based solutions."